ZTS Q1 2018 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

Q1 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.4B+11.0% YoY

Gross Profit

$896M65.6% margin

Operating Income

$461M33.7% margin

Net Income

$352M25.8% margin

EPS (Diluted)

$0.72

QoQ Revenue Growth

-6.4%

Cash Flow

Operating Cash Flow

$389M

Free Cash Flow

$336M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$8.7B

Total Liabilities

$6.7B

Stockholders' Equity

$2.0B

Cash & Equivalents

$1.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.4B	$1.2B	+11.0%
Gross Profit	$896M	$767M	+16.8%
Operating Income	$461M	$368M	+25.3%
Net Income	$352M	$238M	+47.9%

Revenue Segments

Dogs and Cats

$549M40%

Cattle

$416M31%

Swine

$175M13%

Poultry

$136M10%

Horses

$41M3%

Fish

$22M2%

Sheep and Other

$21M2%

Geographic Segments

BRAZIL

$70M24%

CHINA

$64M22%

CANADA

$40M13%

GERMANY

$38M13%

FRANCE

$33M11%

ITALY

$27M9%

SPAIN

$25M8%